TABLE 1.
Deficiency | Region removed by deficiency | Effect on DmcycEJP | Candidate genes in the region |
---|---|---|---|
X chromosome | |||
Suppressors | |||
Df(1)tBA1 | 1A1 to 2A | Suppression | Rbfa |
Df(1)JC19 | 2F6 to 3C5 | Suppression | NC |
Df(1)N73 and Df(1)sqh | 5D1–2 to 5D5–6 | Suppression | roughex, air4 (−) |
Df(1)KA14 | 7F1–2 to 8C6 | Mild suppression | lawc (−), air11 |
Df(1)vN48 | 9F to 10C3–5 | Suppression | dlg |
Df(1)C246 | 11D–E to 12A1–2 | Suppression | BAP60b |
Df(1)RK4 | 12F5–6 to 13A9–B10 | Suppression | NC |
Df(1)sc72b | 13F1 to 14B1 | Suppression | NC |
Df(1)ma13 | 19A1–2 to 20E–F | Suppression | RpS6 |
Enhancers | |||
Df(1)4b18 | 14B8 to 14C1 | Enhancement | NC |
Df(1)N19 | 17A1 to 18A2 | Enhancement | fused |
Third chromosome | |||
Suppressors | |||
Df(3L)HR232 and Df(3L)HR119 | 63C6 to 63D3 | Suppression | sprouty |
Df(3L)GN24 | 63F4–7 to 64C13–15 | Suppression | cdc4 (ago)c |
Df(3L)vin2 and Df(3L)vin5 | 68A2–3 to 68D6 | Suppression | NC 3.2 region (See Table 5) |
Df(3L)brm11 | 71F1–4 to 72D1–10 | Suppression |
Brahma3.5 region (see Table 5) |
Df(3L)81K19 | 73A3 to 74F | Suppression |
argos, Abl, Dab, sina, sinahd3.1 region (Table 5) |
Df(3R)p712 | 84D4–6 to 85B6 | Suppression | pyd(Z01) |
Df(3R)by10 | 85D8–12 to 85F1 | Suppression | hyd (−) |
Df(3R)Cha7 | 90F1–4 to 91F5 | Suppression | NC |
Df(3R)XS | 96A1–7 to 96A21–25 | Mild suppression | NC |
Df(3R)T1P | 97A to 98A1–2 | Mild suppression |
l(3)mbt (−), scribble63S15 region (Table 5) |
Df(3R)awdKRB | 100C6–7 to 100D3–4 | Suppression | tramtrack (−) |
Enhancers | |||
Df(3L)emc5 | 61C3–4 to 62A8 | Enhancement | emc (−), trio (S) Rac1b |
Df(3L)RG7 | 62B8–9 to 62F2–5 | Enhancement | Roughened (Rap1) (−) |
Df(3L)HR370 | 63A1 to 63D10 | Enhancement | NC |
Df(3L)GN50 | 63E1–2 to 64B17 | Enhancement | cdc2-63E (−), Ras64Bb, RfC40 |
Df(3L)66CG28 | 66B8–9 to 66C10 | Enhancement | DNApolα50b |
Df(3L)hi22 | 66D10–11 to 66E1–2 | Enhancement | h (−), dally (−), mcm7b |
Df(3L)AC1 | 67A2 to 67D7–13 | Enhancement | shc, eif-4E, cdk8b |
Df(3L)Cat | 75B8 to 75F1 | Enhancement | Replication-deficient regionb |
Df(3L)rdgC | 77A1 to 77D1 | Enhancement | DNA primase |
Df(3L)PcMK | 78A3 to 79E1 | Enhancement | cyclin H DNApol-etab |
Df(3R)Tp110 | 83C1–2 to 84B1–2 | Enhancement | plx |
Df(3R)eN19 | 93B to 94A | Enhancement | E2F1 |
Df(3R)crbS874 | 95E8–F1 to 95F15 | Enhancement | crb |
Df(3R)3450 | 98E3 to 99A6–8 | Enhancement | string |
Where deficiencies that overlap have the same effect on DmcycEJP, the region common to both deficiencies is given as the cytological region. Candidate genes that are underlined have the same effect on the DmcycEJP phenotype as the corresponding deficiency. Those indicated by (−) have been tested and shown to have no effect on DmcycEJP, while those indicated by (S) have been shown to suppress rather than enhance. NC, there was no candidate satisfying our criteria in the interval. Gene descriptions are as follows: Rbf, Retinoblastoma; roughex (inhibitor of Cyclin A/Cdk1 in the MF); air4, aberrant immune response 4 (blood cell tumor suppressor); lawc (enhancer of TxG mutants); air11, aberrant immune response 11 (blood cell tumor suppressor); dlg, discs-large (cytoarchetectual protein, neoplastic tumor suppressor); BAP60, Brahma-associated protein 60 (Brahma complex protein, chromatin remodeling); RpS6, Ribosomal protein S6 (translation factor, tumor suppressor); fused (protein kinase required for Hh signaling); sprouty (acts antagonistically to the Egfr); brahma (SWI2-related ATPase, chromatin remodeling, negative growth regulator); argos (Egfr ligand, anatogonist of Egfr signaling); Abl (nonreceptor tyrosine protein kinase); dab, disabled (acts synergistically with Abl); sina and sinah (ring finger E3 ubiquitin ligases, protein degradation); pyd, ZO1, and tamou (membrane-associated guanylate kinase); hyd, hyperplastic discs (HECT domain E3 ubiquitin ligase, protein degradation); l(3)mbt, lethal (3) malignant brain tumor (translation factor, tumor suppressor); scribble (cytoarchitectual protein, neoplastic tumor suppressor); tramtrack (neural differentiation inhibitor); emc, extra-macrochaetae (Id-related HLH repressor protein required for cell proliferation in the wing and with hairy for MF progression in the eye); trio (Rac-GEF, required for Rac activation); Rac1 (Rac family GTPase); Roughened (Rap1; Ras-like GTPase); cdc2-63E (cdc2-related protein kinase); Ras64B (Ras-related); RfC40, Replication factor-C40 (DNA replication initiation); DNApolα50, DNA polymerase-α 50-kD subunit (DNA replication); h, hairy (see emc); dally (glypican, cooperates with Wg and other growth factor receptors); mcm7, minichromosome maintenance 7 (DNA replication initiation); shc (adaptor protein required for Egfr signaling); eif-4E (translational initiation factor); cdk8 (cdc2-related protein kinase); DNA primase (DNA replication); cyclin H (Cyclin required for activation of cdk8 protein kinase); DNApol-eta (DNA replication); plx, pollux (a cell adhesion protein related to the human oncogene TRE17; Zhang et al. 1996); E2F1 (S-phase transcription factor); crb, crumbs (apical-lateral membrane protein involved in cell polarity); and string (Cdc25 phosphatase, activator of Cdc2). An unidentified gene essential for DNA replication is located within the 75B8–75F1 region (Smith et al. 1993). For more details see text.
Specific alleles of RBF have been shown to suppress the DmcycEJP phenotype and overexpression of RBF enhances the DmcycEJP rough eye phenotype (Secombe et al. 1998; our unpublished data).
No specific mutation is available to test the interaction.
cdc4 (ago) alleles have been shown to suppress DmcycEJP (Moberg et al. 2001).
sina alleles showed only weak dominant suppression of the DmcycEJP rough eye phenotype; however, a sina-related gene is located next to sina (sinah), and removal of both may account for the suppression observed by the deficiency (M. Coombe, L. Quinn, R. Dickins, J. Secombe and H. Richardson, unpublished results).